Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,616 GBX | +0.98% |
|
+0.09% | +11.47% |
01:18pm | GSK : UBS gives a Buy rating | ZD |
09:12am | GSK : JP Morgan remains a Sell rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.47% | 82.79B | |
+51.82% | 797B | |
+40.72% | 628B | |
-6.88% | 351B | |
+16.95% | 323B | |
+9.49% | 300B | |
+17.08% | 244B | |
+0.90% | 223B | |
+5.30% | 163B | |
-6.29% | 153B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK Starts Appeal Against US State Court Ruling on Zantac Lawsuit